# New England Journal of Medicine

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/new-england-journal-of-medicine/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,390,474 |
| h-index | 1,507 |
| Homepage | http://www.nejm.org/ |
| Open Access | false |
| ISSN-L | 0028-4793 |
| ISSNs | 0028-4793,0096-6762,1533-4406,2331-4710 |
| OpenAlex ID | https://openalex.org/S62468778 |
| Publisher | Massachusetts Medical Society |
| Works | 191,246 |

## Journal papers

Showing 12 of 1323.

- [Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia](https://scholariq.org/papers/early-transmission-dynamics-in-wuhan-china-of-novel-coronavirus-infected/)
- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://scholariq.org/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-cardiovascular-outcomes-and-mortality-in-type-2-diabetes/)
- [Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2](https://scholariq.org/papers/use-of-chemotherapy-plus-a-monoclonal-antibody-against-her2-for-metastatic/)
- [Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization](https://scholariq.org/papers/chronic-kidney-disease-and-the-risks-of-death-cardiovascular-events-and/)
- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-pd-l1-positive-non-small-cell-lung-cancer/)
- [PD-1 Blockade in Tumors with Mismatch-Repair Deficiency](https://scholariq.org/papers/pd-1-blockade-in-tumors-with-mismatch-repair-deficiency/)
- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure](https://scholariq.org/papers/the-effect-of-spironolactone-on-morbidity-and-mortality-in-patients-with-severe/)

## Journal top topics

Showing 8 of 19.

- [Diverse Scientific and Economic Studies](https://scholariq.org/topics/diverse-scientific-and-economic-studies/)
- [Human auditory perception and evaluation](https://scholariq.org/topics/human-auditory-perception-and-evaluation/)
- [Medical History and Innovations](https://scholariq.org/topics/medical-history-and-innovations/)
- [Medical Imaging and Pathology Studies](https://scholariq.org/topics/medical-imaging-and-pathology-studies/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [Health and Medical Research Impacts](https://scholariq.org/topics/health-and-medical-research-impacts/)
- [Health and Conflict Studies](https://scholariq.org/topics/health-and-conflict-studies/)
- [Educational Robotics and Engineering](https://scholariq.org/topics/educational-robotics-and-engineering/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.